Follow
Kausik Datta
Kausik Datta
(formerly) Johns Hopkins University School of Medicine
Verified email at alumni.jh.edu
Title
Cited by
Cited by
Year
Spread of Cryptococcus gattii into Pacific Northwest region of the United States
K Datta, KH Bartlett, R Baer, E Byrnes, E Galanis, J Heitman, L Hoang, ...
Emerging infectious diseases 15 (8), 1185, 2009
3122009
Species-specific Prevalence of Vaginal Candidiasis Among Patients with Diabetes Mellitus and its Relation to their Glycaemic Status
R Goswami, V Dadhwal, S Tejaswi, K Datta, A Paul, RN Haricharan, ...
Journal of Infection 41 (2), 162-166, 2000
2052000
Aspergillosis Complicating Severe Coronavirus Disease
KA Marr, A Platt, JA Tornheim, SX Zhang, K Datta, C Cardozo, ...
Emerging infectious diseases 27 (1), 2020
1792020
The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans
KS Subramaniam, K Datta, E Quintero, C Manix, MS Marks, L Pirofski
The Journal of Immunology 184 (10), 5755-5767, 2010
1222010
Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation
N Chaudhary, K Datta, FB Askin, JF Staab, KA Marr
American journal of respiratory and critical care medicine 185 (3), 301-310, 2012
972012
Immunogenicity and Efficacy of Cryptococcus neoformans Capsular Polysaccharide Glucuronoxylomannan Peptide Mimotope-Protein Conjugates in Human …
RW Maitta, K Datta, A Lees, SS Belouski, L Pirofski
Infection and immunity 72 (1), 196-208, 2004
902004
Cryptococcosis in India: the awakening of a giant?
U Banerjee, K Datta, T Majumdar, K Gupta
Sabouraudia 39 (1), 51-67, 2001
802001
Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care
K Datta, N Jain, S Sethi, A Rattan, A Casadevall, U Banerjee
Journal of Antimicrobial Chemotherapy 52 (4), 683-686, 2003
782003
A multicenter, longitudinal cohort study of cryptococcosis in human immunodeficiency virus–negative people in the United States
KA Marr, Y Sun, A Spec, N Lu, A Panackal, J Bennett, P Pappas, ...
Clinical Infectious Diseases 70 (2), 252-261, 2020
772020
Protective and Nonprotective Human Immunoglobulin M Monoclonal Antibodies to Cryptococcus neoformans Glucuronoxylomannan Manifest Different Specificities …
RW Maitta, K Datta, Q Chang, RX Luo, B Witover, K Subramaniam, ...
Infection and immunity 72 (8), 4810-4818, 2004
722004
Cryptococcus gattii: Emergence in Western North America: Exploitation of a Novel Ecological Niche
K Datta, KH Bartlett, KA Marr
Interdisciplinary Perspectives on Infectious Diseases, 176532, 2009
712009
Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis
SF Dufresne, K Datta, X Li, E Dadachova, JF Staab, TF Patterson, ...
Public Library of Science 7 (8), e42736, 2012
702012
Towards a vaccine for Cryptococcus neoformans: principles and caveats
K Datta, L Pirofski
FEMS yeast research 6 (4), 525-536, 2006
672006
Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan
K Datta, A Lees, L Pirofski
Clinical and Vaccine Immunology 15 (8), 1176-1187, 2008
522008
Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis
KA Marr, K Datta, S Mehta, DB Ostrander, M Rock, J Francis, ...
Clinical Infectious Diseases 67 (11), 1705-1711, 2018
512018
Niche-specific requirement for hyphal wall protein 1 in virulence of Candida albicans
JF Staab, K Datta, P Rhee
PloS one 8 (11), e80842, 2013
452013
Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility
K Datta, P Rhee, E Byrnes III, G Garcia-Effron, DS Perlin, JF Staab, ...
Journal of clinical microbiology 51 (9), 3090-3093, 2013
432013
Serotype distribution of Cryptococcus neoformans in patients in a tertiary care center in India
U Banerjee, K Datta, A Casadevall
Medical Mycology 42 (2), 181-186, 2004
432004
Cryptococcus gattii Infection in Healthy Hosts: A Sentinel for Subclinical Immunodeficiency?
KA Marr, K Datta, L Pirofski, R Barnes
Clinical infectious diseases 54 (1), 153-154, 2012
362012
Immunotherapy of Fungal Infections
K Datta, L Pirofski
Reference Module in Life Sciences (Ed. Oscar Zaragoza), 10.1016/B978-0-12 …, 2017
322017
The system can't perform the operation now. Try again later.
Articles 1–20